KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Total Debt: 2011-2015

Historic Total Debt for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to $30.0 million.

  • Biocryst Pharmaceuticals' Total Debt was N/A to $30.0 million in Q3 2015 from the same period last year, while for Sep 2015 it was $120.0 million, marking a year-over-year change of. This contributed to the annual value of $30.0 million for FY2014, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Total Debt of $30.0 million as of Q3 2015, which was down 0.00% from $30.0 million recorded in Q2 2015.
  • Biocryst Pharmaceuticals' 5-year Total Debt high stood at $30.0 million for Q2 2011, and its period low was $30.0 million during Q2 2011.
  • For the 3-year period, Biocryst Pharmaceuticals' Total Debt averaged around $30.0 million, with its median value being $30.0 million (2015).